Shang Jing, Xue Lanping, Zhao Hongping, Cui Xiaopeng, Shangguan Lijuan, Wang Hailong, Li Xinyi
Department of Neurology, Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
Department of Neurology, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, Taiyuan, China.
Front Neurol. 2024 Sep 16;15:1424069. doi: 10.3389/fneur.2024.1424069. eCollection 2024.
Low serum prealbumin levels have been identified as a predictor of infectious complication in critically ill patients. However, the association in patients with Community-acquired bacterial meningitis (CABM) remains unclear. The aim of this study is to investigate the relationship of prealbumin and the poor outcome of CABM through a retrospective cohort study.
A total of 77 patients of CABM were enrolled. They were divided into good outcome group (GOS: 5) and a bad outcome group (GOS: 1-4). Serum prealbumin and other clinical records were measured within 24 h after admission.
Among the included patients, 38(65.52%) had a bad outcome (the GOS score between 1 and 4). The mean age of the overall cohort was 45.3 ± 15.9 years, and 58.6% of patients were male. The mean prealbumin level in the bad outcome group was 115.4 ± 49.4 mmol/L, while the mean level in the good outcome group was 199.1 ± 49.3 mmol/L ( < 0.001). Individuals with plasma prealbumin level ≤180 mmol/L had a 3.32-fold higher risk of CABM than those with normal plasma prealbumin level [OR = 4.32 (1.02 ~ 18.24), < 0.05].
Reduced plasma prealbumin level is independently associated with the poor outcome of CABM. Plasma prealbumin level might help to identify patients at high risk of bad outcome.
低血清前白蛋白水平已被确定为重症患者感染并发症的预测指标。然而,社区获得性细菌性脑膜炎(CABM)患者中两者的关联仍不清楚。本研究旨在通过回顾性队列研究探讨前白蛋白与CABM不良预后的关系。
共纳入77例CABM患者。他们被分为预后良好组(格拉斯哥预后评分:5分)和预后不良组(格拉斯哥预后评分:1 - 4分)。入院后24小时内检测血清前白蛋白及其他临床记录。
在所纳入的患者中,38例(65.52%)预后不良(格拉斯哥预后评分在1至4分之间)。整个队列的平均年龄为45.3±15.9岁,58.6%的患者为男性。预后不良组的平均前白蛋白水平为115.4±49.4mmol/L,而预后良好组的平均水平为199.1±49.3mmol/L(P<0.001)。血浆前白蛋白水平≤180mmol/L的个体发生CABM的风险比血浆前白蛋白水平正常的个体高3.32倍[比值比=4.32(1.02至18.24),P<0.05]。
血浆前白蛋白水平降低与CABM的不良预后独立相关。血浆前白蛋白水平可能有助于识别预后不良的高危患者。